2 completed, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Unknown 1 |
Follow HCV Infection: new trials by email Literature Review of HCV Infection trials Research Report on HCV Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders Sofosbuvir and Ledipasvir - HCV Infection, Beta Thalassemia Major | Phase 3 | Unknown | Ain Shams University | 24 | 2018-06-11 | 2023-03-06 |
| Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment E/C/F/TAF, F/R/TAF, LDV/SOF - HIV-1 Infection, HCV Infection | Phase 3 | Completed | Gilead Sciences | 150 | 2016-04-01 | 2018-11-14 |
| Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients Peginterferon alfa-2a, ribavirin, amantadine - HCV Infection, Hepatitis C, Chronic | Phase 3 | Completed | University Hospital, Bordeaux | 131 | 2001-11-01 | 2007-06-13 |
Hepatitis C (3) · Hepatitis C, Chronic (1) · beta-Thalassemia (1)
Blood-Borne Infections (3) · Communicable Diseases (3) · Digestive System Diseases (3) · Flaviviridae Infections (3) · Hepatitis (3) · Hepatitis, Viral, Human (3) · Infections (3) · Liver Diseases (3) · RNA Virus Infections (3) · Virus Diseases (3) · Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
ledipasvir, sofosbuvir drug combination (2) · Amantadine (1) · Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Ribavirin (1) · peginterferon alfa-2a (1)
Ain Shams University (1) · Gilead Sciences (1) · University Hospital, Bordeaux (1)
Egypt (1) · France (1) · Puerto Rico (1) · United States (1)
Manal H El-Sayed, M.D (1) · Patrice Couzigou, Pr (1)
2014 (1)